Products - Lower urinary tract symptoms | Topic | NICE

Showing 3 products

Date | Title

Guidance programme: Technology appraisal guidanceRemove ‘Guidance programme: Technology appraisal guidance’ filter

Vibegron for treating symptoms of overactive bladder syndrome (TA999)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
4 September 2024
Mirabegron for treating symptoms of overactive bladder (TA290)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
26 June 2013
Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal) (TA273)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
23 January 2013